Literature DB >> 22583146

Therapeutic potential of Terminalia arjuna in cardiovascular disorders.

Subir K Maulik1, Kewal K Talwar.   

Abstract

The bark of the tree Terminalia arjuna (Roxb.) is widely used in Indian medicine (Ayurveda) for various cardiovascular ailments. The bark has been reported to contain several bioactive compounds. Many experimental studies have reported its antioxidant, anti-ischemic, antihypertensive, and antihypertrophic effects, which have relevance to its therapeutic potential in cardiovascular diseases in humans. Several clinical studies have reported its efficacy mostly in patients with ischemic heart disease, hypertension, and heart failure. However, a major shortcoming in all these experimental and clinical studies is the absence of phytochemical standardization of the extracts. In addition, many clinical studies are poor in terms of design and methods used for generating safety data. This review discusses how to address all these issues for a scientific validation of this medicinal plant.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22583146     DOI: 10.2165/11598990-000000000-00000

Source DB:  PubMed          Journal:  Am J Cardiovasc Drugs        ISSN: 1175-3277            Impact factor:   3.571


  13 in total

1.  Effect of Chinese Medicine Danshen and Indian Ayurvedic Medicine Bark of Arjuna Tree on a Relatively New LOCI Digoxin Assay for Application on the Vista 1500 Analyzer.

Authors:  Amitava Dasgupta; Tamal K Sengupta; Myrtle Johnson
Journal:  J Clin Lab Anal       Date:  2014-05-19       Impact factor: 2.352

2.  A survey of medicinal plants used by the Deb barma clan of the Tripura tribe of Moulvibazar district, Bangladesh.

Authors:  Mohammad Humayun Kabir; Nur Hasan; Md Mahfuzur Rahman; Md Ashikur Rahman; Jakia Alam Khan; Nazia Tasnim Hoque; Md Ruhul Quddus Bhuiyan; Sadia Moin Mou; Rownak Jahan; Mohammed Rahmatullah
Journal:  J Ethnobiol Ethnomed       Date:  2014-02-06       Impact factor: 2.733

3.  Short-Term Adjuvant Therapy with Terminalia arjuna Attenuates Ongoing Inflammation and Immune Imbalance in Patients with Stable Coronary Artery Disease: In Vitro and In Vivo Evidence.

Authors:  Divya Kapoor; Dimple Trikha; Rajesh Vijayvergiya; K K Parashar; Deepak Kaul; Veena Dhawan
Journal:  J Cardiovasc Transl Res       Date:  2015-04-01       Impact factor: 4.132

4.  Arjunolic acid, a peroxisome proliferator-activated receptor α agonist, regresses cardiac fibrosis by inhibiting non-canonical TGF-β signaling.

Authors:  Trisha Bansal; Emeli Chatterjee; Jasdeep Singh; Arjun Ray; Bishwajit Kundu; V Thankamani; Shantanu Sengupta; Sagartirtha Sarkar
Journal:  J Biol Chem       Date:  2017-08-18       Impact factor: 5.157

Review 5.  Terminalia arjuna in Chronic Stable Angina: Systematic Review and Meta-Analysis.

Authors:  Navjot Kaur; Nusrat Shafiq; Harish Negi; Avaneesh Pandey; Srinivas Reddy; Harpreet Kaur; Neelima Chadha; Samir Malhotra
Journal:  Cardiol Res Pract       Date:  2014-01-30       Impact factor: 1.866

Review 6.  Revisiting Terminalia arjuna - An Ancient Cardiovascular Drug.

Authors:  Shridhar Dwivedi; Deepti Chopra
Journal:  J Tradit Complement Med       Date:  2014-10

7.  In vitro and in vivo Evaluation of CYP1A Interaction Potential of Terminalia Arjuna Bark.

Authors:  Alice Varghese; Nancy Pandita; R S Gaud
Journal:  Indian J Pharm Sci       Date:  2014-03       Impact factor: 0.975

8.  Cardioprotective role of methanolic extract of bark of Terminalia arjuna against in-vitro model of myocardial ischemic-reperfusion injury.

Authors:  Gauthaman Karunakaran
Journal:  Anc Sci Life       Date:  2015 Oct-Dec

Review 9.  Medicinal properties of Terminalia arjuna (Roxb.) Wight & Arn.: A review.

Authors:  Augustine Amalraj; Sreeraj Gopi
Journal:  J Tradit Complement Med       Date:  2016-03-20

10.  DNA-based Simultaneous Identification of Three Terminalia Species Targeting Adulteration.

Authors:  Sonal Sharma; Neeta Shrivastava
Journal:  Pharmacogn Mag       Date:  2016-05       Impact factor: 1.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.